Background There is evidence that exposure to mercury (Hg) may be a risk factor for
cardiovascular disease (CVD). Objective To conduct a systematic review of published …

The combined harmful effects of cigarette smoking and hyperglycemia can accelerate
vascular damage in patients with diabetes who smoke, as is well known. Can smoking …

A new cardiometabolic-based chronic disease (CMBCD) model is presented that provides a
basis for early and sustainable, evidence-based therapeutic targeting to promote …

Background Timely recognition of patients with acute coronary syndromes (ACS) is
important for successful treatment. Previous research has suggested that women with ACS …

Stem cell-derived exosomes have been recognized as a potential therapy for cardiovascular
disease. However, the low retention rate of exosomes after transplantation in vivo remains a …

Patients with rheumatoid arthritis (RA) are at high risk of developing cardiovascular disease
(CVD). Inflammation has a pivotal role in the pathogenesis of CVD. RA is an inflammatory …

The prevalence of chronic diseases in the United States and around the world is very high
and not sustainable by most health care systems. While the etiology is complex, many …

Background Cardiovascular disease (CVD) is one of the leading causes of death worldwide.
Our study aimed to investigate the prevalence of two conditions, angina and stroke, and …

Background The Seven Countries study in the 1960s showed that populations in the
Mediterranean region experienced lower coronary heart disease (CHD) mortality probably …

Built environment attributes may be related to cardio‐metabolic diseases (eg type 2
diabetes, heart disease and stroke) and their risk factors, potentially by influencing residents' …